Compounding TPN Admixtures: Then and Now

Journal of Parenteral and Enteral Nutrition

Volumn 27, Issue 6, 2003, Pages 433-438

  Driscoll, David F ^a  

^a Baker Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTTON SEED OIL; FISH OIL; LIPID EMULSION; LIPOFUNDIN; LIPOFUNDIN MCT; LIPOSYN; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; OLIVE OIL;

ARTICLE; ASEPSIS; CLINICAL PROTOCOL; DRUG CONTAMINATION; DRUG FORMULATION; DRUG MIXTURE; DRUG SAFETY; DRUG STABILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION;

GOSSYPIUM HIRSUTUM; SALVIA;

EID: 1642513485     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607103027006433     Document Type: Article

References (44)

1. Pulliam CC, Upton JH: Pharmacy coordinated intravenous admixture and administration service. Am J Hosp Pharm 28:92-101, 1971
2. Anon: Hospital pharmacies falling into line on contamination control. Contam Control 10:19-21, 1971
3. Centers for Disease Control and Prevention: Follow-up on septicemias associated with contaminated intravenous fluids. Morb Mortal Wkly Rep 20:91-92, 110, 1971
4. Ashcraft KW, Leape LL: Candida sepsis complicating parenteral feeding. JAMA 212:454-456, 1970
5. Boeckman CR, Krill CE: Bacterial and fungal infections complicating parenteral alimentation in infants and children. J Pediatr Surg 5:117-126, 1970
6. Curry CR, Quie PG: Fungal septicemia in patients receiving parenteral alimentation. N Engl J Med 285:1221-1225, 1971
7. Brennan MF, O'Connell RC, Rosol JA: The growth of Candida albicans in nutritive solutions given parenterally. Arch Surg 103:705-708, 1971
8. Goldmann DA, Martin WT, Worthington JW: Growth of bacteria and fungi in total parenteral nutrition solutions. Am J Surg 126:314-318, 1973
9. Allen JR: Prevention of infection in patients receiving total parenteral nutrition. Acta Chir Scand 507:405-418, 1981
10. Verschraegen G, Claeys G, Delanghe M, et al: Serotyping and phage typing to identify Enterobacter cloacae contaminating total parenteral nutrition. Eur J Clin Microbiol Infect Dis 7:306-307, 1988
11. Moro ML, Maffei C, Manso E, et al: Nosocomial outbreak of systemic candidiasis associated with parenteral nutrition. Infect Control Hosp Epidemiol 11:27-35, 1990
12. Dugleux G, Le Coutour X, Hecquard C, et al: Septicemia caused by contaminated parenteral nutrition pouches: The refrigerator as an unusual cause. JPEN 15:474-475, 1991
13. Llop JM, Mangues I, Perez JL, et al: Staphylococcus saprophyticus sepsis related to total parenteral nutrition admixtures contamination. JPEN 17:575-577, 1993
14. Two children die after receiving infected TPN solutions. Pharm J 8:3, 1994
15. Freeman J, Glodmann DA, Smith NE, et al: Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care unit. N Engl J Med 323:301-308, 1990
16. Shiro H, Muller E, Takeda S, et al: Potentiation of staphylococcal epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis 171:220-224, 1995
17. Matlow AG, Kitai I, Kirpalani H, et al: A randomized trial of 72-versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy. Infect Control Hosp Epidemiol 20:487-493, 1999
18. Sacks GS, Driscoll DF: Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract 17:284-290, 2002
19. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition: Safe practices for parenteral nutrition formulations. JPEN 22:49-66, 1998
20. Pharmaceutical compounding: Sterile preparations. Pharm Forum 29:940-965, 2003
21. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm 57:1150-1169, 2000
22. Driscoll DF, Sanborn MD, Giampietro K: ASHP guidelines on the safe use of automated compounding devices for the preparation of parenteral nutrition admixtures. Am J Health Syst Pharm 57:1343-1348, 2000
23. Driscoll DF: Delivery of nutritional therapy: Quality assurance of automated compounding devices. Nutrition 12:651-652, 1996
24. Reiter PD: Sterility of intravenous fat emulsion in plastic syringes. Am J Health Syst Pharm 59:1857-1859, 2002
25. Driscoll DF: Total nutrient admixtures: Theory and practice. Nutr Clin Pract 10:114-119, 1995
26. Howard L, Chu R, Feman S, et al: Vitamin A deficiency from long-term parenteral nutrition. Ann Intern Med 93:576-577, 1980
27. Driscoll DF, Bhargava HN, Li L, Zaim, et al: The physicochemical stability of total nutrient admixtures. Am J Hosp Pharm 52:623-634, 1995
28. Food and Drug Administration: FDA safety alert: Hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm 51:1427-1428, 1994
29. Driscoll DF, Newton DW, Bistrian BR: Calcium phosphate precipitation from parenteral nutrition. Am J Hosp Pharm 51:2834-2836, 1994
30. Hill SE, Heldman LS, Goo EDH, et al: Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture. JPEN 20:81-87, 1996
31. Driscoll DF, Bacon MN, Provost PS, et al: Automated compounders for parenteral nutrition admixtures. JPEN 18:385-386, 1994
32. Driscoll DF, You YQ, Bacon MN, et al: Compatibility of inorganic vs. organic phosphate salts in TPN admixtures. JPEN 21:16, S3, 1997
33. Gupta VD: Stability of vitamins in total parenteral nutrition solutions. Am J Hosp Pharm 43:2132, 1986
34. Driscoll DF, Adolph M, Bistrian BR: Lipid emulsions in parenteral nutrition. IN Parenteral Nutrition, Rombeau JL, Rolandelli R (eds). 2001: W. B. Saunders Company, Philadelphia, PA, 2001, pp 35-59
35. Solassol C, Joyeaux H, Etco L, et al: New techniques for long-term intravenous feeding: An artificial gut in 75 patients. Ann Surg 179:519-522, 1974
36. Jeejeebhoy KN, Anderson GH, Nakhooda AF, et al: Metabolic studies in total parenteral nutrition in man. J Clin Invest 57:125-136, 1975
37. Driscoll DF, Baptista RJ, Bistrian BR, et al: Practical considerations regarding the use of total nutrient admixtures. Am J Hosp Pharm 43:416-419, 1986
38. Brown R, Quercia RA, Sigman A: Total nutrient admixture: A review. JPEN 10:650-658, 1986
39. Driscoll DF: Clinical issues regarding the use of total nutrient admixtures. Ann Pharmacother 24:296-303, 1990
40. Driscoll DF, Etzler F, Barber TA, et al: Physicochemical assessments of parenteral lipid emulsions: Light obscuration vs. laser diffraction. Int J Pharm 219:21-37, 2001
41. Driscoll DF: The significance of particle-sizing measurements in the safe use of intravenous fat emulsions. J Disp Sci Tech 23:679-687, 2002
42. Globule size distribution in intravenous emulsions. Pharm Forum 24:6988-6994, 1998
43. Driscoll DF, Ling PR, Quist WC, et al: Tissue damage from unstable fat globules in the reticuloendothelial system (RES) organs of guinea pigs following a 24-hour all-in-one infusion [abstract]. Clin Nutr 21(Suppl 1):63, Abstract P-50, 2002
44. Driscoll DF, Ling PR, Quist WC, et al: Evidence of tissue damage from the infusion of unstable lipid emulsions [abstract]. JPEN 27:S29, Abstract 060, 2003